• Publications
  • Influence
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global
Background Up-to-date evidence about levels and trends in disease and injury incidence, prevalence, and years lived with disability (YLDs) is an essential input into global, regional, and nationalExpand
  • 2,696
  • 31
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic
'The challenge for governments and the health development community more broadly is to heed this knowledge about the comparative effect of health risks...'
  • 1,104
  • 29
Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013
Background Up-to-date evidence on levels and trends for age-sex-specifi c all-cause and cause-specifi c mortality is essential for the formation of global, regional, and national health policies. InExpand
  • 3,030
  • 23
Recognition, diagnosis, and treatment of primary focal hyperhidrosis.
John Hornberger, MD, MS, Kevin Grimes, MD, Markus Naumann, MD, Dee Anna Glaser, MD, Nicholas J. Lowe, MD, Hans Naver, MD, PhD, Samuel Ahn, MD, Lewis P. Stolman, MD, on behalf of the Multi-SpecialtyExpand
  • 320
  • 17
A review of the clinical, economic, and societal burden of treatment-resistant depression: 1996-2013.
OBJECTIVE This literature review assessed the burden of treatment-resistant depression in the United States by compiling published data about the clinical, societal, and economic outcomes associatedExpand
  • 208
  • 13
Cost utility in the United States of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone for the treatment of elderly patients with diffuse large B‐cell lymphoma
Findings from the Groupe d'Etude des Lymphomes Adultes LNH 98‐5 study showed that rituximab added to combined cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) prolongedExpand
  • 53
  • 8
Economic analysis of targeting chemotherapy using a 21-gene RT-PCR assay in lymph-node-negative, estrogen-receptor-positive, early-stage breast cancer.
OBJECTIVE To appraise the economics of a recurrence score (RS), based on an assay that predicts distant recurrence-free survival in lymph-node-negative (LN-), estrogen-receptor-positive (ER+)Expand
  • 155
  • 7
The social and economic burden of treatment-resistant schizophrenia: a systematic literature review
Patients with schizophrenia often fail to respond to an initial course of therapy. This study systematically reviewed the societal and economic burden of treatment-resistant schizophrenia (TRS).Expand
  • 163
  • 7
Eliminating language barriers for non-English-speaking patients.
OBJECTIVES More than 31 million persons living in the United States do not speak English, therefore language discordance between the clinician and patient may hinder delivery of cost-effectiveExpand
  • 194
  • 6
Cost-Effectiveness of a Vaccine To Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults
Context A recent large trial proved that a live attenuated varicella-zoster virus vaccine reduced the incidence and severity of herpes zoster in older adults. Contribution This decision modelExpand
  • 98
  • 6